Tien Liang BioTech Co., Ltd. (4127.TWO)

TWD 36.25

(-0.14%)

Net Debt Summary of Tien Liang BioTech Co., Ltd.

  • Tien Liang BioTech Co., Ltd.'s latest annual net debt in 2023 was -57.55 Million TWD , down -1014.89% from previous year.
  • Tien Liang BioTech Co., Ltd.'s latest quarterly net debt in 2024 Q2 was -72.39 Million TWD , up 11.03% from previous quarter.
  • Tien Liang BioTech Co., Ltd. reported annual net debt of 6.29 Million TWD in 2022, down -83.62% from previous year.
  • Tien Liang BioTech Co., Ltd. reported annual net debt of 38.4 Million TWD in 2021, down -44.4% from previous year.
  • Tien Liang BioTech Co., Ltd. reported quarterly net debt of -72.39 Million TWD for 2024 Q2, up 11.03% from previous quarter.
  • Tien Liang BioTech Co., Ltd. reported quarterly net debt of -12.62 Million TWD for 2023 Q2, down -168.89% from previous quarter.

Annual Net Debt Chart of Tien Liang BioTech Co., Ltd. (2023 - 2019)

Created with Highcharts 11.1.0YearsNet Debt20192019.520202020.520212021.520222022.52023-50000000 TWD0 TWD50000000 TWD100000000 TWD-100000000 TWD

Historical Annual Net Debt of Tien Liang BioTech Co., Ltd. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -57.55 Million TWD -1014.89%
2022 6.29 Million TWD -83.62%
2021 38.4 Million TWD -44.4%
2020 69.07 Million TWD 226.79%
2019 -54.47 Million TWD 0.0%

Peer Net Debt Comparison of Tien Liang BioTech Co., Ltd.

Name Net Debt Net Debt Difference
Allied Biotech Corporation 178.11 Million TWD 132.314%
GeneFerm Biotechnology Co., Ltd. 31.92 Million TWD 280.279%
Easywell Biomedicals, Inc. 123.43 Million TWD 146.628%
TTY Biopharm Company Limited -705.97 Million TWD 91.847%
Synmosa Biopharma Corporation 1.52 Billion TWD 103.783%
Orient EuroPharma Co., Ltd. 3.1 Billion TWD 101.853%
Center Laboratories, Inc. 3.91 Billion TWD 101.469%
Orient Pharma Co., Ltd. 633.6 Million TWD 109.084%
InnoPharmax Inc. -17.85 Million TWD -222.298%
Johnson Chemical Pharmaceutical Works Co., Ltd. -926.77 Million TWD 93.79%
Excelsior Biopharma Inc. -212.51 Million TWD 72.916%
DV Biomed Co., Ltd. 160.7 Million TWD 135.816%
Foresee Pharmaceuticals Co., Ltd. -781.42 Million TWD 92.634%
Handa Pharmaceuticals, Inc. -653.8 Million TWD 91.197%
UniPharma Co., Ltd. -68.36 Million TWD 15.813%
Anxo Pharmaceutical Co., Ltd. 492.4 Million TWD 111.689%
Alar Pharmaceuticals Inc. -738.05 Million TWD 92.202%
Winston Medical Supply Co., Ltd. -191.81 Million TWD 69.993%
Mercury Biopharmaceutical Corporation -1.94 Million TWD -2859.177%
Bioray Biotech Co., Ltd -27.23 Million TWD -111.354%
TSH Biopharm Corporation Limited -568.74 Million TWD 89.88%